Molecular Signaling in CSCs

CSCs rely on several critical signaling pathways that regulate their survival, proliferation, and ability to resist therapies. This track focuses on understanding key molecular pathways like Wnt/β-catenin, Hedgehog, Notch, and TGF-β, which govern CSC behavior. The dysregulation of these pathways often results in uncontrolled cell growth, maintenance of stemness, and enhanced survival capabilities of CSCs. Researchers aim to identify how mutations or aberrant signaling contribute to cancer initiation and metastasis. Targeting these signaling pathways holds great promise for therapies that selectively eliminate CSCs without harming normal stem cells. By understanding the molecular underpinnings of CSC regulation, novel inhibitors and therapeutic strategies can be developed to block CSC-driven tumorigenesis and overcome treatment resistance, leading to better clinical outcomes.

    Related Conference of Molecular Signaling in CSCs

    November 25-26, 2024

    7th International Conference on Anti-Cancer Drugs & Therapies

    Vancouver, Canada
    November 28-29, 2024

    14th World Congress on Breast Cancer

    Paris, France
    December 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Dubai, UAE
    December 11-12, 2024

    34th Experts Meet On Cancer Research & Therapy

    Paris, France
    December 12-13, 2024

    44th Euro Congress on Cancer Science & Therapy

    Rome, Italy
    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    10th World Conference on Breast and Cervical Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands

    Molecular Signaling in CSCs Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in